GANX Stock Analysis: Buy, Sell, or Hold?
GANX - Gain Therapeutics, Inc. Common Stock
$1.79
-0.04 (-2.19%)
▼
5d:
+1.13%
30d:
-5.79%
90d:
-30.35%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 19, 2026
0d
Get Alerted When GANX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
8 traders called GANX this week
94% bullish • 1 bearish
94% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GANX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GANX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GANX is currently trading at $1.79, which is considered extended relative to its 30-day fair value range of $1.73 to $1.93.
Technical Outlook: Technically, GANX is in a downtrend. Immediate support is located at $1.60, while resistance sits at $2.05.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.20 (+302.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GANX is in a downtrend. Immediate support is located at $1.60, while resistance sits at $2.05.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.20 (+302.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.73 -
$1.93
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 302.2% below Wall St target ($7.20)
Trading Range Analysis
30-Day Trading Range
$1.73 -
$1.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.60
Resistance Level
$2.05
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.98
Wall Street Target
$7.20
(+302.2%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 03, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
Data refreshes hourly during market hours. Next update: 7:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GANX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 55 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 55 HOLD |
